Business Context and Reporting Period
This Form 8-K filing by Healthcare Trust of America, Inc. (NYSE: HTA) and its operating partnership, Healthcare Trust of America Holdings, LP, reports material events occurring on September 5, 2019, with the report filed on September 6, 2019. The Company is a real estate investment trust focused on healthcare properties.
Key Financial Metrics and Capital Structure
The filing details a significant capital raise and debt restructuring rather than operational financial performance metrics such as revenue or profit.
- New Debt Issuance: The Company entered into an underwriting agreement to issue $250.0 million of 3.500% Senior Notes due 2026 and $650.0 million of 3.100% Senior Notes due 2030.
- Net Proceeds: The Offering is expected to generate approximately $899.6 million in net proceeds, excluding accrued interest and after deducting underwriting discounts and estimated offering expenses.
- Debt Redemption: The Company intends to use proceeds to redeem all outstanding 3.375% Senior Notes due 2021 and 2.950% Senior Notes due 2022.
- Other Uses of Proceeds: Remaining funds will be used to repay a portion of the unsecured revolving credit and term loan facility and for general corporate purposes, including working capital and real estate investment.
Material Changes Versus Prior Period
This filing represents a material change in the Company's capital structure through the extension of its debt maturity profile.
- Debt Maturity Extension: The Company is replacing near-term debt obligations (due 2021 and 2022) with longer-term obligations (due 2026 and 2030).
- Interest Rate Profile: The new notes carry interest rates of 3.500% and 3.100%, replacing existing notes with rates of 3.375% and 2.950%.
- Liquidity Impact: The transaction is expected to improve liquidity by reducing near-term refinancing risks and providing capital for general corporate purposes.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the consummation of the Offering and the redemption of the 2021 and 2022 Notes. Management intends to close the transaction and execute the redemptions on September 20, 2019.
- Redemption Pricing: The redemption price for the 2021 and 2022 Notes will be determined based on the Adjusted Treasury Rate on the third business day prior to the redemption date, plus accrued interest.
- Risks: The Company notes that actual results may differ materially from expectations due to risks associated with consummating the offering and other factors identified in its most recent Form 10-K.
- Covenants: The new indentures include restrictive covenants, such as limitations on incurring additional indebtedness and requirements to maintain a pool of unencumbered assets.
Important Facts for Investor Verification
- Verify the final closing date of the $900 million offering and the exact net proceeds received.
- Confirm the final redemption price paid for the 2021 and 2022 Notes based on the Adjusted Treasury Rate.
- Review the updated debt maturity schedule to assess the impact on future refinancing needs.
- Monitor the Company's compliance with the new restrictive covenants regarding unencumbered assets and additional indebtedness.